Bioassays for anticancer activities

Janice McCauley1, Ana Zivanovic, Danielle Skropeta

  • 1School of Chemistry, University of Wollongong, Wollongong, Australia.

Insights

This study details two key anticancer screening methods: MTT/MTS assays for cell cytotoxicity and kinase inhibition assays for molecular targets. These economical assays are vital for characterizing potential anticancer drug activity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • The MTT/MTS assay is a widely used colorimetric method for assessing preliminary anticancer activity of compounds and natural products.
  • This assay provides an indication of whole cell cytotoxicity but does not identify specific molecular targets.
  • Kinase inhibition assays are crucial for identifying molecular targets, as kinases play key roles in physiological processes and their inhibitors show anticancer potential.

Purpose of the Study:

  • To describe the methodologies for performing in vitro MTT/MTS cytotoxicity assays.
  • To outline the procedures for conducting kinase enzyme inhibition assays.
  • To highlight these assays as essential, economical, and versatile tools for anticancer drug screening.

Main Methods:

  • In vitro MTT/MTS cell proliferation assay for cytotoxicity.
  • Kinase enzyme inhibition assays for molecular target identification.
  • Adaptable methods for screening against specific cancer cell lines and targeted disease processes.

Main Results:

  • The MTT/MTS assay offers a reliable, colorimetric assessment of cytotoxicity across various cell lines.
  • Kinase inhibition assays identify specific enzyme targets, crucial for understanding anticancer mechanisms.
  • Combined, these assays provide a comprehensive characterization of anticancer activity.

Conclusions:

  • MTT/MTS and kinase inhibition assays are indispensable, cost-effective laboratory techniques for preliminary anticancer screening.
  • These assays are highly versatile and can be modified for targeted cancer research.
  • Routine performance of these assays aids in the characterization and development of novel anticancer agents.